Chinese Journal of Dermatology ›› 2017, Vol. 50 ›› Issue (11): 784-789.doi: 10.3760/cma.j.issn.0412-4030.2017.11.002
• Guidelines and Consensus • Previous Articles Next Articles
Pediatric Dermatology Group, Chinese Society of Dermatology
Received:2017-01-06
Revised:2017-07-25
Online:2017-10-15
Published:2017-11-02
Pediatric Dermatology Group, Chinese Society of Dermatology. Diagnosis and treatment of atopic dermatitis in children in China: an expert consensus statement （2017）[J]. Chinese Journal of Dermatology, 2017, 50(11): 784-789.doi:10.3760/cma.j.issn.0412-4030.2017.11.002
| ［1］ | Weidinger S, Novak N. Atopic dermatitis［J］. Lancet, 2016, 387（10023）: 1109⁃1122. DOI: 10.1016/S0140⁃6736（15）00149⁃X. |
| ［2］ | Katayama I, Kohno Y, Akiyama K, et al. Japanese guideline for atopic dermatitis 2014［J］. Allergol Int, 2014, 63（3）: 377⁃398. DOI: 10.2332/allergolint.14⁃RAI⁃0769. |
| ［3］ | 顾恒, 尤立平, 刘永生, 等. 我国10城市学龄前儿童特应性皮炎现况调查［J］. 中华皮肤科杂志, 2004, 37（1）: 29⁃31. DOI: 10.3760/j.issn:0412⁃4030.2004.01.011. |
| ［4］ | Xu F, Yan S, Li F, et al. Prevalence of childhood atopic dermatitis: an urban and rural community⁃based study in Shanghai, China［J/OL］. PLoS One, 2012, 7（5）: e36174. http://journals.plos.org/plosone/ article?id=10.1371/journal.pone.0036174. DOI: 10.1371/journal.pone.0036174. |
| ［5］ | Guo Y, Li P, Tang J, et al. Prevalence of atopic dermatitis in Chinese children aged 1⁃7 ys［J］. Sci Rep, 2016, 6: 29751. DOI: 10.1038/srep29751. |
| ［6］ | Mao W, Mao J, Zhang J, et al. Atopic eczema: a disease modulated by gene and environment［J］. Front Biosci （Landmark Ed）, 2014, 19: 707⁃717. DOI: 10.2741/4237. |
| ［7］ | Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report［J］. Allergy, 2006, 61（8）: 969⁃987. DOI: 10.1111/j.1398⁃9995.2006.01153.x. |
| ［8］ | Bradley M, Kockum I, Söderhäll C, et al. Characterization by phenotype of families with atopic dermatitis［J］. Acta Derm Venereol, 2000, 80（2）: 106⁃110. |
| ［9］ | Thomsen SF, Ulrik CS, Kyvik KO, et al. Importance of genetic factors in the etiology of atopic dermatitis: a twin study［J］. Allergy Asthma Proc, 2007, 28（5）: 535⁃539. DOI: 10.2500/aap2007.28.3041. |
| ［10］ | Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases［J］. N Engl J Med, 2011, 365（14）: 1315⁃1327. DOI: 10.1056/NEJMra1011040. |
| ［11］ | Kim JE, Kim JS, Cho DH, et al. Molecular mechanisms of cutaneous inflammatory disorder: atopic dermatitis［J］. Int J Mol Sci, 2016, 17（8）. DOI: 10.3390/ijms17081234. |
| ［12］ | Boguniewicz B, Abrams M, Fonacier L. Atopic dermatitis and contact dermatitis//Adelman DC, Casale TB, Corren J, et al. Manual of allergy and immunology［M］. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2012: 494. |
| ［13］ | Danso MO, van Drongelen V, Mulder A, et al. TNF⁃α and Th2 cytokines induce atopic dermatitis⁃like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents［J］. J Invest Dermatol, 2014, 134（7）: 1941⁃1950. DOI: 10.1038/jid.2014.83. |
| ［14］ | Peng W, Novak N. Pathogenesis of atopic dermatitis［J］. Clin Exp Allergy, 2015, 45（3）: 566⁃574. DOI: 10.1111/cea.12495. |
| ［15］ | Czarnowicki T, Esaki H, Gonzalez J, et al. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen （CLA）（+） TH2/TH1 cell imbalance, whereas adults acquire CLA（+） TH22/TC22 cell subsets［J］. J Allergy Clin Immunol, 2015, 136（4）: 941⁃951.e3. DOI: 10.1016/j.jaci.2015.05.049. |
| ［16］ | Palmer CN, Irvine AD, Terron⁃Kwiatkowski A, et al. Common loss⁃of⁃function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis［J］. Nat Genet, 2006, 38（4）: 441⁃446. DOI: 10.1038/ng1767. |
| ［17］ | Leung DY. Our evolving understanding of the functional role of filaggrin in atopic dermatitis［J］. J Allergy Clin Immunol, 2009, 124（3）: 494⁃495. DOI: 10.1016/j.jaci.2009.07.041. |
| ［18］ | Henderson J, Northstone K, Lee SP, et al. The burden of disease associated with filaggrin mutations: a population⁃based, longitudinal birth cohort study［J］. J Allergy Clin Immunol, 2008, 121（4）: 872⁃877. e9. DOI: 10.1016/j.jaci.2008.01.026. |
| ［19］ | Zhang H, Guo Y, Wang W, et al. Mutations in the filaggrin gene in Han Chinese patients with atopic dermatitis［J］. Allergy, 2011, 66（3）: 420⁃427. DOI: 10.1111/j.1398⁃9995.2010.02493.x. |
| ［20］ | Li M, Chen X, Chen R, et al. Filaggrin gene mutations are associated with independent atopic asthma in Chinese patients［J］. Allergy, 2011, 66（12）: 1616⁃1617. DOI: 10.1111/j.1398⁃9995.2011.02713.x. |
| ［21］ | Li M, Cheng R, Shi M, et al. Analyses of FLG mutation frequency and filaggrin in isolated ichthyosis vulgaris （IV） and atopic dermatitis⁃associated IV［J］. Br J Dermatol, 2013, 168（6）: 1335⁃1338. DOI: 10.1111/bjd.12206. |
| ［22］ | Bieber T. Atopic dermatitis［J］. N Engl J Med, 2008, 358（14）:1483⁃1494. DOI: 10.1056/NEJMra074081. |
| ［23］ | Krämer U, Weidinger S, Darsow U, et al. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema［J］. J Invest Dermatol, 2005, 124（3）: 514⁃523. DOI: 10.1111/j.0022⁃202X.2005.23625.x. |
| ［24］ | Lack G. Clinical practice. Food allergy［J］. N Engl J Med, 2008, 359（12）: 1252⁃1260. DOI: 10.1056/NEJMcp0800871. |
| ［25］ | Goldenberg A, Silverberg N, Silverberg JI, et al. Pediatric allergic contact dermatitis: lessons for better care［J］. J Allergy Clin Immunol Pract, 2015, 3（5）: 661⁃667; quiz 668. DOI: 10.1016/j.jaip.2015.02.007. |
| ［26］ | De Benedetto A, Agnihothri R, McGirt LY, et al. Atopic dermatitis: a disease caused by innate immune defects?［J］. J Invest Dermatol, 2009, 129（1）: 14⁃30. DOI: 10.1038/jid.2008. 259. |
| ［27］ | Niebuhr M, Werfel T. Innate immunity, allergy and atopic dermatitis［J］. Curr Opin Allergy Clin Immunol, 2010, 10（5）: 463⁃468. DOI: 10.1097/ACI.0b013e32833e3163. |
| ［28］ | Schachner LA, Hansen RC. Pediatric dermatology［M］. 3rd ed. London: Mosby, 2003. |
| ［29］ | Shi M, Zhang H, Chen X, et al. Clinical features of atopic dermatitis in a hospital⁃based setting in China［J］. J Eur Acad Dermatol Venereol, 2011, 25（10）: 1206⁃1212. DOI: 10.1111/j.1468⁃3083.2010.03953.x. |
| ［30］ | Li M, Liu Q, Liu J, et al. Mutations analysis in filaggrin gene in northern China patients with atopic dermatitis［J］. J Eur Acad Dermatol Venereol, 2013, 27（2）: 169⁃174. DOI: 10.1111/j.1468⁃3083.2011.04435.x. |
| ［31］ | Choi WJ, Ko JY, Kim JW, et al. Prevalence and risk factors for atopic dermatitis: a cross⁃sectional study of 6,453 Korean preschool children［J］. Acta Derm Venereol, 2012, 92（5）: 467⁃471. DOI: 10.2340/00015555⁃1252. |
| ［32］ | Saeki H, Iizuka H, Mori Y, et al. Prevalence of atopic dermatitis in Japanese elementary schoolchildren［J］. Br J Dermatol, 2005, 152（1）: 110⁃114. DOI: 10.1111/j.1365⁃2133.2004.06271.x. |
| ［33］ | Kyoya M, Kawakami T, Soma Y. Serum thymus and activation⁃regulated chemokine （TARC） and interleukin⁃31 levels as biomarkers for monitoring in adult atopic dermatitis［J］. J Dermatol Sci, 2014, 75（3）: 204⁃207. DOI: 10.1016/j.jdermsci.2014.06.001. |
| ［34］ | Gustafsson D, Sjöberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow⁃up to 7 years of age［J］. Allergy, 2000, 55（3）: 240⁃245. DOI: 10.1034/j.1398⁃9995.2000.00391.x. |
| ［35］ | Huang JT, Abrams M, Tlougan B, et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity［J］. Pediatrics, 2009, 123（5）: e808⁃e814. DOI: 10.1542/peds.2008⁃2217. |
| ［36］ | Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema （atopic dermatitis） part I［J］. J Eur Acad Dermatol Venereol, 2012, 26（8）: 1045⁃1060. DOI: 10.1111/j.1468⁃3083.2012.04635.x. |
| ［37］ | Lack G, Fox D, Northstone K, et al. Factors associated with the development of peanut allergy in childhood［J］. N Engl J Med, 2003, 348（11）: 977⁃985. DOI: 10.1056/NEJMoa013536. |
| ［38］ | Boussault P, Léauté⁃Labrèze C, Saubusse E, et al. Oat sensitization in children with atopic dermatitis: prevalence, risks and associated factors［J］. Allergy, 2007, 62（11）: 1251⁃1256. DOI: 10.1111/j.1398⁃9995.2007.01527.x. |
| ［39］ | Wollenberg A, Wetzel S, Burgdorf WH, et al. Viral infections in atopic dermatitis: pathogenic aspects and clinical management［J］. J Allergy Clin Immunol, 2003, 112（4）: 667⁃674. DOI: 10.1016/S0091. |
| ［40］ | Horimukai K, Morita K, Narita M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis［J］. J Allergy Clin Immunol, 2014, 134（4）: 824⁃830. e6. DOI: 10.1016/j.jaci.2014.07.060. |
| ［41］ | Berth⁃Jones J, Damstra RJ, Golsch S, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study［J］. BMJ, 2003, 326（7403）: 1367. DOI: 10.1136/bmj.326.7403.1367. |
| ［42］ | Huang X, Xu B. Efficacy and safety of tacrolimus versus pimecrolimus for the treatment of atopic dermatitis in children: a network meta⁃analysis［J］. Dermatology, 2015, 231（1）: 41⁃49. DOI: 10.1159/000381948. |
| ［43］ | Dähnhardt⁃Pfeiffer S, Dähnhardt D, Buchner M, et al. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis［J］. J Dtsch Dermatol Ges, 2013, 11（5）: 437⁃443. DOI: 10.1111/ddg.12074. |
| ［44］ | Aschoff R, Schwanebeck U, Bräutigam M, et al. Skin physiolo⁃gical parameters confirm the therapeutic efficacy of pimecrolimus cream 1 in patients with mild⁃to⁃moderate atopic dermatitis［J］. Exp Dermatol, 2009, 18（1）: 24⁃29. DOI: 10.1111/j.1600⁃0625.2008.00756.x. |
| ［45］ | Wollenberg A, Reitamo S, Atzori F, et al. Proactive treatment of atopic dermatitis in adults with 0.1 tacrolimus ointment［J］. Allergy, 2008, 63（6）: 742⁃750. DOI: 10.1111/j.1398⁃9995. 2008.01683.x. |
| ［46］ | Thaçi D, Reitamo S, Gonzalez EMA, et al. Proactive disease management with 0.03 tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, compara⁃tive study［J］. Br J Dermatol, 2008, 159（6）: 1348⁃1356. DOI: 10.1111/j.1365⁃2133.2008.08813.x. |
| ［47］ | Langeland T, Fagertun HE, Larsen S. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi⁃crossover⁃designed study［J］. Allergy, 1994, 49（1）: 22⁃26. DOI: 10.1111/j.1398⁃9995.1994.tb00768.x. |
| ［48］ | Wahlgren CF, Hägermark O, Bergström R. The antipruritic effect of a sedative and a non⁃sedative antihistamine in atopic dermatitis［J］. Br J Dermatol, 1990, 122（4）: 545⁃551. DOI: 10.1111/j.1365⁃2133.1990.tb14732.x. |
| ［49］ | Munday J, Bloomfield R, Goldman M, et al. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component［J］. Dermatology, 2002, 205（1）: 40⁃45. DOI: 10.1159/000063138. |
| ［50］ | Klein PA, Clark RA. An evidence⁃based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis［J］. Arch Dermatol, 1999, 135（12）: 1522⁃1525. |
| ［51］ | National Collaborating Centre for Women′s and Children′s Health （UK）. Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years［M］. London: RCOG Press, 2007. |
| ［52］ | Wollenberg A, Zoch C, Wetzel S, et al. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases［J］. J Am Acad Dermatol, 2003, 49（2）: 198⁃205. DOI: 10.1067/S0190⁃9622（03）00896⁃X. |
| No related articles found! |
|
